Publisher： Karger
E-ISSN： 1421-9913|51|1|15-20
ISSN： 0014-3022
Source： European Neurology, Vol.51, Iss.1, 2004-01, pp. : 15-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis
European Neurology, Vol. 59, Iss. 3-4, 2007-11 ,pp. :
Access to resources
Recommend
Is Interferon Effective and Safe for Relapsing-Remitting Multiple Sclerosis?
Neuroepidemiology, Vol. 21, Iss. 6, 2002-11 ,pp. :
Treatment of Relapsing-Remitting Multiple Sclerosis: Current and Future Algorithms
European Neurology, Vol. 72, Iss. 1, 2014-09 ,pp. :
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. :